Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.
文献类型:期刊论文
作者 | Yin, Rutie; Li, Ning; Wu, Lingying; Wang, Jing; Zhu, Jianqing; Pan, Lingya; Kong, Beihua; Zheng, Hong; Liu, Jihong; Wu, Xiaohua |
刊名 | JOURNAL OF CLINICAL ONCOLOGY |
出版日期 | 2022-06-01 |
卷号 | 40 |
ISSN号 | 0732-183X |
资助项目 | Zai Lab (Shanghai) Co. Ltd. ; National Major Scientific and Technological Special Project for Significant New Drugs Development in 2020, China[2020ZX09101-014] |
WOS研究方向 | Oncology |
语种 | 英语 |
出版者 | LIPPINCOTT WILLIAMS & WILKINS |
WOS记录号 | WOS:000863680301608 |
资助机构 | Zai Lab (Shanghai) Co. Ltd. ; National Major Scientific and Technological Special Project for Significant New Drugs Development in 2020, China |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129905] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Zai Lab Shanghai Co Ltd, Shanghai, Peoples R China 2.Zai Lab US LLC, Boston, MA USA 3.Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Peoples R China 4.Liaoning Canc Hosp & Inst, Shenyang, Peoples R China 5.Sichuan Univ, Dept Gynecol & Obstet, Chengdu, Peoples R China 6.Sichuan Univ, West China Second Univ Hosp, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, Chengdu, Peoples R China 7.Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China 8.Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China 9.Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China 10.Hunan Canc Hosp, Changsha, Peoples R China |
推荐引用方式 GB/T 7714 | Yin, Rutie,Li, Ning,Wu, Lingying,et al. Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
APA | Yin, Rutie.,Li, Ning.,Wu, Lingying.,Wang, Jing.,Zhu, Jianqing.,...&Hou, Jianmei.(2022).Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy..JOURNAL OF CLINICAL ONCOLOGY,40. |
MLA | Yin, Rutie,et al."Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。